期刊文献+

胺碘酮治疗骨伤科围术期快速性心律失常的疗效观察 被引量:3

Efficacy of Amiodarone for Tachyarrhythmia in Orthopedic Patients During Perioperative Period
下载PDF
导出
摘要 目的:观察静脉应用胺碘酮治疗骨伤科围术期快速性心律失常的临床疗效及安全性。方法:收集184例围术期快速性心律失常的骨伤科患者,以随机抽样法分为2组,治疗组(92例)先静脉注射负荷量的胺碘酮,继以静脉滴注维持,对照组(92例)给予注射用酒石酸美托洛尔静脉注射,1日1次,观察2组治疗心律失常的疗效及药品不良反应。结果:治疗组总有效率达95.65%(88/92),对照组为69.57%(64/92),2组比较,差异有统计学意义(χ2=8.12,P=0.016)。药品不良反应方面,治疗组有9例发生不良反应,对照组为10例,2组比较,差异无统计学意义(P>0.05)。结论:静脉应用胺碘酮治疗骨伤科围术期快速性心律失常安全、有效。 OBJECTIVE:To evaluate the efficacy and safety of amiodarone for tachyarrhythmia in orthopedic patients during perioperative period.METHODS: 184 orthopedic patients with tachyarrhythmia during perioperative period were randomly divided into two groups of 92 each: the treatment group was intravenously administered with loading dose of amiodarone then maintained by drip infusion,and the control group was intravenously administered with metoprolol tartrate injection once daily.The efficacy for arrhythmia and the adverse drug reactions in the two groups were followed.RESULTS: The total response rate in the treatment group vs.the control group was 95.65%(88/92) vs.69.57%(64/92),showing significant differences between the two groups(χ2=8.12,P=0.016).9 cases in the treatment group vs.10 in the control group presented with adverse drug reactions,showing no significant differences between the two groups(P0.05).CONCLUSION: Intravenous administration of amiodarone was proved to be safe and effective for tachyarrhythmia in orthopedic patients during perioperative period.
出处 《中国医院用药评价与分析》 2012年第12期1110-1112,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 胺碘酮 快速性心律失常 围术期 Amiodarone Tachyarrhythmia Perioperative period
  • 相关文献

参考文献7

二级参考文献49

  • 1李玮,张俊,乔燕舞,夏琳,傅莹.高浓度胺碘酮静脉泵入与静脉炎关系的临床研究[J].心血管康复医学杂志,2004,13(6):594-595. 被引量:163
  • 2韩庆奇,徐志云,张宝仁,黄盛东,邹良建,徐激斌,韩林,赵铁军,何斌,沈美芳.胺碘酮在预防冠状动脉旁路移植术后房颤中的作用研究[J].第二军医大学学报,2006,27(9):973-976. 被引量:7
  • 3[2]The CASCADE investigators:The Cascade study-randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle[J].Am J Cardiol 1993,13:442-449.
  • 4[3]Levine JH,Massumi A,Scheinman MM,et al,Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias.The Intravenous Amiodarone Multicenter Trial Group[J].J Am Coll Cardiol,1996,27:67 -75.
  • 5[4]Kudenchuk PJ,Coobb L.A,Copass M.K et al.Amiodarone for resuscition after out-of -Hospital cardiac arrest due to Ventricular fibrillaton[J].N Eng JMed,1999,341:871-894.
  • 6[5]AHA.The Most Important Change in the Inten National ECC and CRP Guiderline[J].Circulation,2000,102(supplel):112-128.
  • 7[6]Burkart F,Pfisterer M,Kiowski W,et al.Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias:Basel Antiarrhythmic Study of Infarct Survival(BASIS)[J].J Am Coll Cardiol,1990,16:1711-1718.
  • 8Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588
  • 9Hammill SC.Cardiac arrhythmias[J].JACC,2004,44(suppl 2):16A
  • 10Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741

共引文献468

同被引文献24

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部